• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1991 Fiscal Year Final Research Report Summary

Anti-tumor Response induced by Autologous Plasma : Basic Studies and Clinical Trials.

Research Project

Project/Area Number 01570757
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Digestive surgery
Research InstitutionShimane Medical University

Principal Investigator

YAMAMOTO Tsuyoshi  Shimane Medical University, Dept. of Surgery I, Assistant Professor, 医学部, 講師 (30135561)

Project Period (FY) 1989 – 1990
KeywordsPlasma perfusion / Protein A / High molar salts / Antitumor responses / Tumor necrosis / Complements
Research Abstract

==INTRODUCTION== An enthusiasm, shown during the '80s, towards antitumor host responses observed at plasma perfusion over immobilized protein A seems to have subsided. It so happened possibly because of the toxicity problems, of unestablished working mechanism and of rather limited clinical benefits. The present study was undertaken to conquer the difficulties by developing a non-bacterial methodology, and to carry out clinical trials for improved benefits.
==RESULTS== A : Using rabbits and Vx2 carcinoma ; 1. Ex-vivo modulation of serum or plasma with high molar NaCl (1.5 M) or KCl (0.5 M), as well as protein A, have achieved significant prolongations of the survival time. 2. Normal sera (autologous), as well as the supernatant fraction of 3.5% PEG precipitation, did achieve the host response. 3. The response was abrogated when ; a) serum was treated at 56 C for 30 min prior to modulation with 1.5 M NaCl or b) 1.5 M NaCl-treated serum was given at 24th hr of tumor inoculation. 4. Electr … More on microscopy detected increase in cytoplasmic materials in the intercellular space as early as 3 hr after infusion of 25 ml protein A-treated plasma. B : Clinical studies ; 1. An infusion of NaCl or KCl treated serum or plasma attained an acute response in the tumor but without any serious generalized complication. 2. Normal plasma (treated with 0.5 M KCl) was also attained the response in patients with breast adenocarcinoma by gross observation (3/3) and by studies with LM (3/3) and EM (1/1). 3. Combine use of chemotherapy and plasma-therapy attained benefits more than the assumed algebraic sum of each modality alone. 4. In vitro cytotoxicity by protein A- treated serum was not observed unless the tumor cells were suspended in the autologous (tumor bearing) serum. 4. Serum treated with 0.5 M KCl or 1.5 M NaCl for 30 min at room temperature showed elevations of levels of C4a, C3a and C5a.
==Conclusions and suggestions== These findings suggest that the response induced by ex-vivo modulated sarum or plasma is beneficial, that infusion of activated C components, especially those of C3, might be the key for the response, though the infused materials themselves are not cytotoxic and the response in the host is antigen dependent. Less

  • Research Products

    (9 results)

All Other

All Publications (9 results)

  • [Publications] 安部 まこと: "乳癌患者の免疫学的パラメ-タの検討ーとくにtwoーcolor分析による末梢血リンパ球の解析についてー" 日本臨床免疫学会会誌. 14. 158-165 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山本 剛史: "担癌生体の血己血清による抗腫瘍現象:Vx2腫瘍移植家兎における血清の高張NaClまたはKCl処理による観察" 日本癌治療学会誌. 26. 2226-2237 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岡田 孝之: "Vx2家兎におけるproteinA潅流血漿投与による抗腫瘍現象の経時的、組織学的検討" 日本癌治療学会誌. 26. 2394-2401 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] YAMAMOTO,T.: "Anti-tumor Response Induced by Reinfusion of plasma after ex-vivo Treating with high motar NaCl or KCl." Journal of Cancer Research and Clinical Oncology. Suppl.16. 293-293 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] OKADA,T.: "A serial Histological and Ultrastractural Study on the Antitumor Response After Reinfusion of seram Perfused over Immobilzed Protein A." Journal of Cancer Research and Clinical Oncology. Suppl.16. 374-374 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] YAMAMOTO,T.: "Anti-tumor Response after Infusion of ex-vivo modulated Serum or Plasma;basic Atudies and Clinical trials" Int.J.Cancer.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Abe, M., Yamamoto, T., Okada, T., and Nakase, A.: "Evaluation of immunological parameters in patients with breast cancer --analysis of peripheral blood lymphocyte subpopulations by two-color flow cytometery--" Jpn. J. Clin. Immun.14(2). 158-165 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamamoto, T., Okada, T., Abe, M., Yano, S., Nakase, A., and Yoshioka, T.: "Antitumor Response by Reinfusion of Autologous Serum after Ex-vivo Modulation : A Study with Serum Treated with High Molar KCl or NaCl in Rabbits Bearing Vx2 Carcinoma." J. Jpn. Soc. Cancer Ther.26(10). 2226-2237 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okada, T., Yamamoto, T., Abe, M., Yano, S., Nakase, A., and Yoshioka, T.: "Sequential Histological and Ultrastructural Study on the Acute Anti-tumor Response after Infusion of Plasma Perfused over Immobilized Protein A." J. Jpn. Soc. Cancer Ther.26(11). 2394-22401 (1991)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi